个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Xu Chunwei[1,2,3] ; Zhang Yongchang[4] ; Wang Wenxian[2] ; Wang Qian[5] ; Li Ziming[6] ; Song Zhengbo[2] ; Wang Jiandong[7] ; Yu Jinpu[8] ; Liu Jingjing[9] ; Zhang Shirong[10] ; Cai Xiuyu[11] ; Wu Ming[12] ; Zhan Ping[3] ; Liu Hongbing[3] ; Lv Tangfeng[3] ; Miao Liyun[13] ; Min Lingfeng[14] ; Li Jiancheng[15] ; Liu Baogang[16] ; Yuan Jingping[17] ; Jiang Zhansheng[18] ; Lin Gen[19] ; Chen Xiaohui[20] ; Pu Xingxiang[21] ; Rao Chuangzhou[22] ; Lv Dongqing[23] ; Yu Zongyang[24] ; Li Xiaoyan[25] ; Tang Chuanhao[26] ; Zhou Chengzhi[27] ; Zhang Junping[28] ; Guo Hui[29] ; Chu Qian[30] ; Meng Rui[31] ; Liu Xuewen[32] ; Wu Jingxun[33] ; Hu Xiao[34] ; Fang Min[34] ; Zhou Jin[35] ; Zhu Zhengfei[36] ; Chen Xiaofeng[37] ; Pan Weiwei[38] ; Pang Fei[39] ; Zhou Yuxiang[39] ; Jian Qijie[39] ; Wang Kai[39] ; Wang Liping[40] ; Zhu Youcai[41] ; Yang Guocai[42] ; Lin Xinqing[27] ; Cai Jing[43] ; Liang Lijun[12] ; Feng Huijing[28] ; Wang Lin[44] ; Du Yingying[45] ; Yao Wang[46] ; Shi Xuefei[47] ; Niu Xiaomin[6] ; Yuan Dongmei[3] ; Yao Yanwen[3] ; Huang Jianhui[48] ; Zhang Yinbin[49] ; Sun Pingli[50] ; Wang Hong[51] ; Ye Mingxiang[3] ; Wang Dong[3] ; Wang Zhaofeng[3] ; Hao Yue[2] ; Wang Zhen[52] ; Wan Bing[53] ; Lv Donglai[54] ; Yu Genhua[55] ; Li Anna[56] ; Kang Jin[56] ; Zhang Jiatao[56] ; Zhang Chao[56] ; Chen Huafei[41] ; Shi Lin[57] ; Ye Leiguang[16] ; Wang Gaoming[58] ; Wang Yina[59] ; Gao Feng[60] ; Zhou Wei[1] ; Hu Chunxiu[61] ; Wei Jianguo[62] ; Li Bihui[63] ; Li Zhongwu[64] ; Li Yuan[65] ; Liu Zhefeng[51] ; Yang Nong[3] ; Wu Lin[21] ; Wang Qiming[66] ; Huang Wenbin[67] ; Hong Zhuan[68] ; Wang Guansong[69] ; Fang Meiyu[4] ; Fang Yong[70] ; Zhu Xixu[52] ; Du Kaiqi[41] ; Ji Jiansong[71] ; Shen Yi[72] ; Zhang Yiping[4] ; Ma Shenglin[73] ; Song Yong[3] ; Lu Yuanzhi[74] ; Liu Anwen[43,*1] ; Fang Wenfeng[75,*2] ; Zhong Wenzhao[56,*3] ;
机构： [1]Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, People's Republic of China. [2]Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Zhejiang, People's Republic of China. [3]Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China. [4]Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China. [5]Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, People's Republic of China. [6]Department of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China. [7]Department of Pathology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China. [8]Department of Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China. [9]Department of Thoracic Cancer, Jilin Cancer Hospital, Jilin, People's Republic of China. [10]Translational Medicine Research Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Cancer Center, Zhejiang University School of Medicine, Hangzhou, People's Republic of China. [11]Department of VIP Inpatient, Sun Yet-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China. [12]Department of Thoracic Surgery, Second Affiliated Hospital of Zhejiang University School of Medicine, Cancer Center, Zhejiang University, Hangzhou, People's Republic of China. [13]Department of Respiratory Medicine, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China. [14]Department of Respiratory Medicine, Clinical Medical School of Yangzhou University, Subei People's Hospital of Jiangsu Province, Yangzhou, People's Republic of China. [15]Department of Radiation Oncology, Fujian Medical University Cancer Hospital &amp [16]Fujian Cancer Hospital, Fuzhou, People's Republic of China. [16]Department of Oncology, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China. [17]Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China. [18]Derpartment of Integrative Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China. [19]Department of Medical Oncology, Fujian Medical University Cancer Hospital &amp [21]Fujian Cancer Hospital, Fuzhou, People's Republic of China. [20]Department of Thoracic Surgery, Fujian Medical University Cancer Hospital &amp [23]Fujian Cancer Hospital, Fuzhou, People's Republic of China. [21]Department of Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China. [22]Department of Radiotherapy and Chemotherapy, Hwamei Hospital, University of Chinese Academy of Sciences, Ningbo, People's Republic of China. [23]Department of Pulmonary Medicine, Taizhou Hospital of Wenzhou Medical University, Taizhou, People's Republic of China. [24]Department of Respiratory Medicine, the 900th Hospital of the Joint Logistics Team (the Former Fuzhou General Hospital), Fujian Medical University, Fuzhou, People's Republic of China. [25]Department of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China. [26]Department of Medical Oncology, Peking University International Hospital, Beijing, People's Republic of China. [27]State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University(The First Affiliated Hospital of Guangzhou Medical University), Guangzhou, People's Republic of China. [28]Department of Thoracic Oncology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, People's Republic of China. [29]Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China. [30]Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China. [31]Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China. [32]Department of Oncology, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China. [33]Department of Medical Oncology, the First Affiliated Hospital of Medicine, Xiamen University, Xiamen, People's Republic of China. [34]Zhejiang Key Laboratory of Radiation Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Zhejiang, People's Republic of China. [35]Department of Medical Oncology, Sichuan Cancer Hospital &amp [39]Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology, Chengdu, People's Republic of China. [36]Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China. [37]Department of Oncology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, People's Republic of China. [38]Department of Cell Biology, College of Medicine, Jiaxing University, Jiaxing, People's Republic of China. [39]Department of Medical, Shanghai OrigiMed Co, Ltd, Shanghai, People's Republic of China. [40]Department of Oncology, Baotou Cancer Hospital, Baotou, People's Republic of China. [41]Department of Thoracic Disease Diagnosis and Treatment Center, Zhejiang Rongjun Hospital, The Third Affiliated Hospital of Jiaxing University, Jiaxing, People's Republic of China. [42]Department of Thoracic Surgery, Zhoushan Hospital, Wenzhou Medical University, Zhejiang, People's Republic of China. [43]Department of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China. [44]Department of Pathology, Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital, Taiyuan, People's Republic of China. [45]Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China. [46]Department of Interventional Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China. [47]Department of Respiratory Medicine, Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, People's Republic of China. [48]Department of Oncology, Lishui Municipal Central Hospital, Lishui, People's Republic of China. [49]Department of Oncology, the Second Affiliated Hospital of Medical College, Xi'an Jiaotong University, Xi'an, People's Republic of China. [50]Department of Pathology, The Second Hospital of Jilin University, Changchun, People's Republic of China. [51]Senior Department of Oncology, The 5th Medical Center of PLA General Hospital, Beijing, People's Republic of China. [52]Department of Radiation Oncology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China. [53]Department of Respiratory Medicine, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, People's Republic of China. [54]Department of Clinical Oncology, The 901 Hospital of Joint Logistics Support Force of People Liberation Army, Hefei, People's Republic of China. [55]Department of Radiation Oncology, Zhebei Mingzhou Hospital, Huzhou, People's Republic of China. [56]Guangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou, People's Republic of China. [57]Department of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China. [58]Department of Thoracic Surgery, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou, People's Republic of China. [59]Department of Oncology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People's Republic of China. [60]Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China. [61]Department of Cancer Radiotherapy and Chemotherapy, Zhejiang Queue Hospital, Quzhou, People's Republic of China. [62]Department of Pahtology, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, People's Republic of China. [63]Department of Oncology, The Second Affiliated Hospital of Guilin Medical University, Guilin, People's Republic of China. [64]Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Pathology, Peking University Cancer Hospital &amp [69]Institute, Beijing, People's Republic of China. [65]Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China. [66]Department of Internal Medicine, The Affiliated Cancer Hospital of Zhengzhou University Henan Cancer Hospital, Zhengzhou, People's Republic of China. [67]Department of Pathology, the First Affiliated Hospital of Henan University of Science and Technology, Luoyang, People's Republic of China. [68]Department of Medical Oncology, Jiangsu Cancer Hospital, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, People's Republic of China. [69]Institute of Respiratory Diseases, Xinqiao Hospital, Third Military Medical University, Chongqing, People's Republic of China. [70]Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, People's Republic of China. [71]Department of Radiology, Lishui Municipal Central Hospital, Lishui, People's Republic of China. [72]Department of Thoracic Surgery, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China. [73]Department of Oncology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou Cancer Hospital, Cancer Center, Zhejiang University School of Medicine, Hangzhou, People's Republic of China. [74]Department of Clinical Pathology, The First Affiliated Hospital Of Jinan University, Guangzhou, People's Republic of China. [75]Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
出处：
DOI： 10.1111/1759-7714.14847
ISSN：

关键词： diagnosis thymic carcinoma thymic epithelial tumor thymoma treatment

摘要：
Thymic epithelial tumors (TETs) are a relatively rare type of thoracic tumor, accounting for less than 1% of all tumors. The incidence of TETs is about 3.93/10000 in China, slightly higher than that of European and American countries. For resectable TETs, complete surgical resection is recommended. Radiotherapy or chemotherapy may be used as postoperative adjuvant treatment. Treatment for advanced, unresectable TETs consist mainly of radiotherapy and chemotherapy, but there is a lack of standard first- and second-line treatment regimens. Recently, targeted therapies and immune checkpoint inhibitors have shown promising outcomes in TETs. Based on the currently available clinical evidences and the opinions of the national experts, the Thymic Oncology Group of Yangtze River Delta Lung Cancer Cooperation Group (East China LUng caNcer Group, ECLUNG; Youth Committee) established this Chinese expert consensus on the clinical diagnosis and treatment of TETs, covering the epidemiology, diagnosis, treatment, prognosis and follow-up of TETs.© 2023 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.

语种：
外文
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类 | 3 区 医学
小类 | 4 区 肿瘤学 4 区 呼吸系统
最新[2023]版：
大类 | 3 区 医学
小类 | 4 区 肿瘤学 4 区 呼吸系统
JCR分区：
出版当年[2023]版：
Q2 RESPIRATORY SYSTEM Q3 ONCOLOGY
最新[2023]版：
Q2 RESPIRATORY SYSTEM Q3 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者：
第一作者机构： [1]Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou, People's Republic of China. [2]Department of Chemotherapy, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Zhejiang, People's Republic of China. [3]Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
通讯机构： [*1]Department of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang Jiangxi 330006, People’s Republic of China. [*2]Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong 510060, People’s Republic of China. [*3]Guangdong Lung Cancer Institute, Guangdong Provincial Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, School of Medicine, Guangzhou Guangdong 510080, People’s Republic of China.
推荐引用方式(GB/T 7714)：
Xu Chunwei,Zhang Yongchang,Wang Wenxian,et al.Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors[J].THORACIC CANCER.2023,14(12):1102-1117.doi:10.1111/1759-7714.14847.
APA：
Xu Chunwei,Zhang Yongchang,Wang Wenxian,Wang Qian,Li Ziming...&Zhong Wenzhao.(2023).Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors.THORACIC CANCER,14,(12)
MLA：
Xu Chunwei,et al."Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors".THORACIC CANCER 14..12(2023):1102-1117

相关文献

[1]Thymic epithelial tumor medical treatment: A narrative review [2]The IASLC/ITMIG thymic epithelial tumors staging project: Proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors(Open Access) [3]Long-Term Survival After Surgical Treatment of Thymic Carcinoma: A Retrospective Analysis from the Chinese Alliance for Research of Thymoma Database [4]The IASLC/ITMIG thymic epithelial tumors staging project: Proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors(Open Access) [5]The IASLC/ITMIG thymic epithelial tumors staging project: Proposals for the T component for the forthcoming (8th) edition of the TNM classification of malignant tumors(Open Access) [6]Long-Term Survival after Surgical Treatment for Thymic Carcinoma [7]Pretreatment biopsy for histological diagnosis and induction therapy in thymic tumors [8]CT-guided percutaneous radiofrequency ablation in the treatment of stage I thymoma [9]Intrathyroid thymic carcinoma: clinicopathological features and whole exome sequencing analysis [10]Acute Pancreatitis: Diagnosis and Treatment

资源点击量：43370 今日访问量：0 总访问量：3120 更新日期：2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号